Stockscreener 앱 받기
1.045
0.95%
-0.01
전일 마감가:
$1.055
열려 있는:
$1.07
하루 거래량:
28,339
Relative Volume:
0.29
시가총액:
$35.98M
수익:
-
순이익/손실:
-
주가수익비율:
-11.85
EPS:
-0.0882
순현금흐름:
-
1주 성능:
+2.45%
1개월 성능:
-8.33%
6개월 성능:
-28.91%
1년 성능:
-87.92%
1일 변동 폭
$1.03
$1.09
1주일 범위
$0.9801
$1.09
52주 변동 폭
$0.51
$9.35
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
명칭
Jupiter Neurosciences Inc
전화
(561) 406-6154
주소
1001 NORTH US HWY 1, JUPITER
JUNS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.045 | 36.32M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jupiter Neurosciences Inc 주식(JUNS)의 최신 뉴스
Will Jupiter Neurosciences Inc. stock split again soonGlobal Trade Effects & High Return Wealth Building - ulpravda.ru
Jupiter Neurosciences expands equity financing through SEPA advances - MSN
What margin trends mean for Jupiter Neurosciences Inc. stockInflation Impact on Stocks & Small Investment Big Gains - bollywoodhelpline.com
Jupiter Neurosciences Expands Equity Financing Through SEPA Advances - TipRanks
Jupiter Neurosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6 - marketscreener.com
The best and worst-performing stocks of 2025 | 2025-12-22 | Investing News - Stockhouse
Jupiter Neurosciences Shareholders Approve Key Governance Measures - TipRanks
The best and worst-performing stocks of 2025 - MSN
New Highs: What margin trends mean for Jupiter Neurosciences Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Stock Analysis: What margin trends mean for Jupiter Neurosciences Inc. stockMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Will Jupiter Neurosciences Inc. stock sustain high P E ratiosEarnings Performance Report & Technical Pattern Based Signals - Улправда
Will Jupiter Neurosciences Inc. stock benefit from AI adoptionStop Loss & Daily Growth Stock Investment Tips - DonanımHaber
Can Jupiter Neurosciences Inc. stock maintain growth trajectoryMarket Sentiment Review & Low Risk High Win Rate Picks - Улправда
Why Jupiter Neurosciences Inc. stock remains on buy listsQuarterly Trade Review & Stepwise Trade Execution Plans - Улправда
Fed Meeting: Can Jupiter Neurosciences Inc. stock maintain growth trajectoryJuly 2025 Rallies & Reliable Entry Point Trade Alerts - Улправда
Jupiter Neurosciences Achieves Regulatory and Commercial Milestones in First Year as Public Company - citybuzz -
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon | Corporate - EQS News
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon - NewMediaWire
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq - Yahoo Finance
Jupiter Neurosciences Marks Transformational First Year as - GlobeNewswire
Why Jupiter Neurosciences Inc. stock attracts global investorsWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum - Yahoo Finance
Jupiter Neurosciences (NASDAQ: JUNS) to Join NobleCon21 Emerging Growth Equity Conference - Stock Titan
Published on: 2025-11-27 23:20:01 - moha.gov.vn
Jupiter Neurosciences files rospectus related to resale of up to 10 million shares of our common stock by selling stockholder - marketscreener.com
Jupiter Neurosciences Inc Stock Analysis and ForecastPortfolio Diversification Tips & Watch Expert Picks Before They Rally - earlytimes.in
How Jupiter Neurosciences Inc. stock reacts to global recession fearsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Will Jupiter Neurosciences Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
How Jupiter Neurosciences Inc. stock benefits from strong dollar2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsIndex Update & Weekly Breakout Stock Alerts - newser.com
A activity2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Why hedge funds are buying Jupiter Neurosciences Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is Jupiter Neurosciences Inc. stock safe for conservative investorsProfit Target & Consistent Return Investment Signals - newser.com
Will Jupiter Neurosciences Inc. stock continue dividend increasesJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Jupiter Neurosciences Inc (JUNS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):